Alzheimer's Disease Clinical Trials in Maryland

30 recruiting studies across 1 city

Browse by City

All Trials in Maryland

Phase

Trial	Phase	Sponsor	Dist.
Clinical Trial on Agitation in Alzheimer's Dementia	Phase 2	IGC Pharma, LLC	<1 mi
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant	Phase 3	Eidos Therapeutics, a BridgeBio company	<1 mi
Longitudinal Early-onset Alzheimer's Disease Study Protocol	—	Indiana University	<1 mi
Trial of CORT108297 to Attenuate the Effects of Acute Stress in the Allocortex (CORT-X)	Phase 2	Johns Hopkins University	<1 mi
Medicare Anti-Aβ mAb Coverage With Evidence Development (CED) Study	—	Centers for Medicare and Medicaid Services/ Coverage and Analysis Group	<1 mi
Amyloid PET Imaging in the Baltimore Longitudinal Study of Aging	—	National Institute on Aging (NIA)	<1 mi
Global Blood-Brain Barrier Disruption and Post-Stroke Cognitive Decline	—	Johns Hopkins University	<1 mi
HEARS-NPS: Addressing Hearing Loss as a Common Unmet Contributor of Neuropsychiatric Symptoms	N/A	Johns Hopkins University	<1 mi
Music Therapy for Patients With Alzheimer's Disease	N/A	Johns Hopkins University	<1 mi
Cognitive Vulnerability to Stress in Individuals at Risk for Alzheimer's Disease	N/A	Johns Hopkins University	<1 mi
Psilocybin for Depression in People With Mild Cognitive Impairment or Early Alzheimer's Disease	Early 1	Johns Hopkins University	<1 mi
Vestibular Therapy in Alzheimer's Disease	N/A	Johns Hopkins University	<1 mi
Targeting Cognition in Early Alzheimer's Disease by Improving Sleep With Trazodone	Phase 2	Johns Hopkins University	<1 mi
Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease	Phase 2	Lighthouse Pharmaceuticals, Inc.	8 mi
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)	Phase 3	Bristol-Myers Squibb	33 mi
A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)	Phase 3	Bristol-Myers Squibb	33 mi
PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI)	Phase 1	National Institute of Mental Health (NIMH)	34 mi
PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease	Phase 1	National Institute of Mental Health (NIMH)	34 mi
Late Onset Alzheimer's Disease	—	Columbia University	36 mi
Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease	Phase 2	Celgene	36 mi
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease	Phase 3	Bristol-Myers Squibb	36 mi
DECIDE: Dyads and Families	N/A	Emory University	36 mi
DC Longitudinal Study on Aging and Specimen Bank	—	Georgetown University	36 mi
Crownlands Observing Progression With Neurons Study	—	Crownlands	36 mi
A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease	Phase 3	Hoffmann-La Roche	39 mi
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies	Phase 3	Hoffmann-La Roche	39 mi
Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)	Phase 3	Karuna Therapeutics, Inc., a Bristol Myers Squibb company	39 mi
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)	Phase 3	Karuna Therapeutics, Inc., a Bristol Myers Squibb company	44 mi
A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)	Phase 2	Eli Lilly and Company	48 mi
Open-label Extension Study in Participants With Early Alzheimer's Disease	Phase 2	GlaxoSmithKline	48 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.